Amyris hits jackpot with $255m deal for cannabinoid development

By Becky Bargh | Published: 6-Feb-2019

The CBD cosmetic ingredient is gaining widespread traction across the beauty category as more governments relax rule on its consumption

You need to be a subscriber to read this article.
Click here to find out more.

Sustainable ingredients producer Amyris has landed a multi million dollardeal to develop and commercialise cannabinoid products.

The $255m agreement includes

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like